GDF15 and metabolic dysfunction-associated steatotic liver disease: Furthermore, the bulk liver RNA-Seq data from the large MASLD cohort, as well as the O-link proteomics analysis of sera from that cohort, indicate that the levels of GDF15 mRNA and protein increase with the severity of MASLD fibrosis in humans (Supplemental Figure 2, C and D).